Beijing Strong Biotechnologies,Inc.

300406

CNE100001Y26

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
18.49 ^CNY	+4.17%		+8.32%	-3.19%

Apr. 25	Beijing Strong Biotechnologies,Inc. Announces Final Cash Dividend (Tax Included) (A Shares) for 2023, Payable on 07 May 2024	CI
Apr. 01	Beijing Strong Biotechnologies,Inc. Proposes Final Cash Dividend for 2023	CI

Beijing Strong Biotechnologies, Inc. Proposes Final Cash Dividend for the Year 2022

April 20, 2023 at 03:33 pm EDT

Beijing Strong Biotechnologies, Inc. announced on 20 April 2023 the profit distribution proposal of final cash dividend per ten shares (tax included) of CNY 1.00000000 for the year 2022.

Latest news about Beijing Strong Biotechnologies,Inc.

Beijing Strong Biotechnologies,Inc. Announces Final Cash Dividend (Tax Included) (A Shares) for 2023, Payable on 07 May 2024	Apr. 24	CI
Beijing Strong Biotechnologies,Inc. Proposes Final Cash Dividend for 2023	Apr. 01	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	Apr. 01	CI
Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	Jan. 03	CI
Tianfu Energy Chairman Proposes Buyback of Up to 30 Million Yuan Shares	Dec. 13	MT
Neo-Neon CFO Steps Down; Successor Named	Nov. 20	MT
ASIA COPPER WEEK-China to expand imports of scrap copper -industry association	Nov. 15	RE
Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-24	CI
Tranche Update on Beijing Strong Biotechnologies,Inc.'s Equity Buyback Plan announced on July 21, 2023.	23-10-11	CI
Beijing Strong Biotechnologies,Inc. Approves Executive Appointments	23-09-25	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-09	CI
Beijing Strong Biotechnologies, Inc. announces an Equity Buyback for CNY 80 million worth of its shares.	23-07-21	CI
Beijing Strong Biotechnologies, Inc. authorizes a Buyback Plan.	23-07-20	CI
Beijing Strong Biotechnologies, Inc. Announces Dividend on Share A for 2022, Payable on May 22, 2023	23-05-16	CI
Beijing Strong Biotechnologies, Inc. Approves Cash Dividend for 2022	23-05-12	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Beijing Strong Biotechnologies, Inc. Proposes Final Cash Dividend for the Year 2022	23-04-20	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-19	CI
Tranche Update on Beijing Strong Biotechnologies, Inc.'s Equity Buyback Plan announced on March 7, 2022.	22-12-07	CI
Beijing Strong Biotechnologies, Inc.'s Equity Buyback announced on May 7, 2022, has expired with 2,867,000 shares, representing 0.49% for ¥50 million.	22-12-06	CI
Beijing Strong Biotechnologies, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
Factbox-China's new political elites and their connection to Xi	22-10-24	RE
'Alarm Bells' Ring as China Shuffles Economic Leaders at Critical Time	22-10-10	MT
Tranche Update on Beijing Strong Biotechnologies, Inc.'s Equity Buyback Plan announced on March 7, 2022.	22-10-09	CI

Chart Beijing Strong Biotechnologies,Inc.

Duration

Period

Chart Beijing Strong Biotechnologies,Inc.

More charts

Beijing Strong Biotechnologies Inc. is a China-based company mainly engaged in the research and development, manufacture and sales of in vitro diagnostic reagents. The Companyâs in vitro diagnostic reagents are mainly used in liver, renal, blood fat, glycometabolism and other fields. The Company is also engaged in the manufacture and sales of in vitro diagnostic equipment and the leasing of equipment. The Company operates businesses in domestic and overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-28 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Beijing Strong Biotechnologies,Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

18.49

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
BEIJING STRONG BIOTECHNOLOGIES,INC.	-3.19%	1.44B
BIOMÉRIEUX	+1.69%	12.8B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-7.57%	7.61B
DIASORIN S.P.A.	+3.22%	5.41B
AUTOBIO DIAGNOSTICS CO., LTD.	+0.93%	4.51B
LANTHEUS HOLDINGS, INC.	+8.50%	4.49B
ANDON HEALTH CO., LTD.	+9.21%	2.73B
VITROLIFE AB	-13.87%	2.02B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-11.63%	1.73B
MYRIAD GENETICS, INC.	+1.93%	1.64B

Diagnostic & Testing Substances